PHILADELPHIA-Cancer Treatment Centers of America bought Parkview Hospital from an affiliate of Santa Barbara, CA-based Tenet Healthcare Corp. Tenet shuttered the revenue-losing facility in North Philadelphia last September during a corporate restructuring in which it closed or sold more than a dozen hospitals nationwide. This is Arlington Heights, IL-based CTCA’s first foray into the Northeast.

Financial terms of the sale were undisclosed. CTCA announced that plans for a $44-million renovation of the 200-bed, 273,800-sf facility and its conversion into a 40-bed specialty hospital would begin immediately. Robert Mayo, CTCA’s vice chairman, says he expects it to open by October 2005. The adjoining, 78,000-sf medical office building, which is a part of the sale and has remained open, will be undisturbed by the renovation and change of ownership.

Another Philadelphia cancer specialty hospital, Fox Chase Cancer Center, has a 100-bed capacity and is initiating construction of a 300,000-sf research pavilion along with a modernization of its existing facility. CTCA currently operates regional medical centers in Zion, IL and Tulsa, OK along with the Seattle Cancer Treatment and Wellness Center.

Tenet owns and operates five hospitals in greater Philadelphia: Hahnemann University Hospital, Graduate Hospital, Roxborough Memorial, and St. Christopher’s Hospital for Children in Philadelphia County and Warminster Hospital in Bucks County.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dig Deeper



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join now!

  • Free unlimited access to's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including and

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.